Cancer
Hedgehog pathway inhibitors (vismodegib)
Drugs that block Smoothened, the switch of the Hedgehog pathway, which is abnormally active in nearly all basal cell carcinomas; used when the tumour is locally advanced or metastatic and cannot be treated by surgery or radiotherapy.
آلية العمل
- Normally PTCH1 restrains Smoothened (SMO); Hedgehog ligand releases it, activating GLI transcription factors.
- In basal cell carcinoma, loss of PTCH1 (or activating SMO mutations) switches the pathway on permanently.
- Vismodegib and sonidegib bind and inhibit SMO, switching off GLI-driven growth.
الأهداف الجزيئية
- Smoothened (SMO): Antagonist
أدوية Hedgehog pathway inhibitors (vismodegib)
- Vismodegib (By mouth.)
- Sonidegib
الاستخدامات العلاجية
- Locally advanced basal cell carcinoma not suitable for surgery or radiotherapy
- Metastatic basal cell carcinoma
الأمراض التي يعالجها
الآثار الجانبية
- Muscle spasms
- Hair loss
- Loss of taste and weight loss
- Fatigue
موانع الاستعمال حسب الحالة
- Pregnancy (ممنوع): Hedgehog signalling patterns the embryo: severe birth defects or fetal death. Strict contraception for both sexes, and no blood donation.
- Breastfeeding (ممنوع): It may harm the infant.
مكتوب من
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 54, Cancer Chemotherapy, Hedgehog pathway inhibitors
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 61, Dermatologic Pharmacology, Basal cell carcinoma: hedgehog inhibitors
مرجع تعليمي، وليس استشارة طبية أو تشخيصاً أو علاجاً.